Reduction of Sleep-disordered Breathing after Physostigmine
The DOI matches its Crossref record; 36 of the 37 references it cites were found in a registry or an index.
Abstract
The cholinesterase inhibitor physostigmine (PHYS) was investigated in a double-blind, placebo-controlled, randomized, crossover trial of 10 male patients with moderate to severe obstructive sleep apnea. PHYS (0.12 μg/minute/kg, 7-hour infusion) reduced mean apnea/hypopnea index (AHI) by 13.6 (95% confidence interval [CI], 2.2–25.1) corresponding to 21.4% (95% CI, –5.5 to 47.9) and increased minimum SaO2 by 8.7% (95% CI, –0.3 to 17.7) corresponding to 23.2% (95% CI, 4.8–41.3). During the last third of the night, coinciding with predicted plasma concentration steady state, non-REM sleep AHI decreased by 19.2 (95% CI, 0.1–38.3) or 14.9% (95% CI, −43.6 to 77.7) and REM AHI by 33.8 (95% CI, 13.7–54.0) or 67.5% (95% CI, 49.7–85.3). Mean total sleep time was reduced by 74 minutes (95% CI, 33.9–114.9), but patients with the least pronounced sleep shortening had the largest reduction of AHI (r = 0.73, p < 0.02). The nocturnal decline in heart rate was reduced by PHYS. Moreover, resting (early-night placebo heart rate) was positively correlated with proportional reduction of REM apnea index (r = 0.69, p < 0.02). Body mass index was negatively correlated with reduction of REM AHI (r = 0.77, p < 0.02). This, predominantly REM-related, reduction of obstructive sleep apnea after PHYS may provide a new treatment option if the effects are maintained in long-term studies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“and there was an inverse relationship with BMI, such that slimmer subjects had a greater fall in AHI.”
From Non-CPAP therapies in obstructive sleep apnoea (2011) · cites this paper as [135]
In the citing paper
“In a single night study 10 subjects had an AHI of 41 on physostigmine compared with 54 on placebo 135.”
From Non-CPAP therapies in obstructive sleep apnoea (2011) · cites this paper as [135]
In the citing paper
“The greatest impact was on apnoeas during REM sleep”
From Non-CPAP therapies in obstructive sleep apnoea (2011) · cites this paper as [135]
Citations
Cites
Rechtschaffen, A. (1968) · Medical Entomology and Zoology · Cited by 12,637
Pathogenesis of upper airway occlusion during sleep
Remmers, J. E., deGroot, W. J., Sauerland, E. K., & Anch, A. M. (1978) · Journal of Applied Physiology · doi:10.1152/jappl.1978.44.6.931 · Cited by 1,885 · cited 1×
“demonstrated reduced tonic and phasic activity coinciding with airway collapse ( 6 ).”
BackgroundBenefit of Atrial Pacing in Sleep Apnea Syndrome
Garrigue, S., Bordier, P., Jaïs, P., Shah, D. C., Hocini, M., Raherison, C., Tunon De Lara, M., Haïssaguerre, M., & Clementy, J. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa011919 · Cited by 339 · cited 1×
“It cannot be excluded that alteration of autonomic activity resulted in autonomic changes that, as recently implied in other studies of sleep apnea using cardiac pacing ( 37 ), may have stabilized the respiratory pattern and pharyngeal caliber by interaction with the ventilatory loop gain (7).”
ResultPhysical Findings and the Risk for Obstructive Sleep Apnea
SCHELLENBERG, J. B., MAISLIN, G., & SCHWAB, R. J. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.162.2.9908123 · Cited by 323 · cited 1×
“apertures ( 3 ) as well as acquired functional changes including attenuated upper airway”
BackgroundRespiratory Arousal From Sleep: Mechanisms and Significance
Berry, R. B., & Gleeson, K. (1997) · Sleep · doi:10.1093/sleep/20.8.654 · Cited by 308
Determinants of ventilatory instability and variability
Khoo, M. C. K. (2000) · Respiration Physiology · doi:10.1016/s0034-5687(00)00157-2 · Cited by 304 · cited 1×
“gain" as a cause of repetitive upper airway collapse (7, 8 ).”
BackgroundHistological Indications of a Progressive Snorers Disease in an Upper Airway Muscle
FRIBERG, D., ANSVED, T., BORG, K., CARLSSON-NORDLANDER, B., LARSSON, H., & SVANBORG, E. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.2.96-06049 · Cited by 298 · cited 1×
“sensory function (4) and altered muscle structure ( 5 ) appear to be common in OSA.”
BackgroundThe Pharmacology of Physostigmine
Triggle, D. J., Mitchell, J. M., & Filler, R. (1998) · CNS Drug Reviews · doi:10.1111/j.1527-3458.1998.tb00059.x · Cited by 165 · cited 1×
“including muscle contraction via muscle end-plate depolarization at the neuromuscular junction, increased salivary secretion as a result of cholinomimetic effects in major and intramucosal salivary glands ( 9 ).”
BackgroundThe Association Between Daytime Sleepiness and Sleep-Disordered Breathing in NREM and REM Sleep
(2002) · Sleep · doi:10.1093/sleep/25.3.307 · Cited by 130
Physostigmine restores3H-acetylcholine efflux from Alzheimer brain slices to normal level
Nilsson, L. M., Nordberg, A. K., Hardy, J., Wester, P. O., & Winblad, B. G. (1986) · Journal of Neural Transmission · doi:10.1007/bf01243353 · Cited by 116 · cited 1×
“acetylcholine content in several animal species as well as in man in a study of brain slices from Alzheimer patients ( 25 ).”
BackgroundNeurotransmitters in central respiratory control
Burton, M. D., & Kazemi, H. (2000) · Respiration Physiology · doi:10.1016/s0034-5687(00)00153-5 · Cited by 111 · cited 1×
“medulla oblongata (31, 32 ) as well in chemosensory signaling in the carotid body (33).”
BackgroundTemperature Thresholds in the Oropharynx of Patients with Obstructive Sleep Apnea Syndrome
Larsson, H., Carlsson-Nordlander, B., Lindblad, L. E., Norbeck, O., & Svanborg, E. (1992) · American Review of Respiratory Disease · doi:10.1164/ajrccm/146.5_pt_1.1246 · Cited by 109
Buccafusco, J. J. (1996) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06940-6 · Cited by 108
Obstructive sleep apnea is related to a thalamic cholinergic deficit in MSA
Gilman, S., Chervin, R. D., Koeppe, R. A., Consens, F. B., Little, R., An, H., Junck, L., & Heumann, M. (2003) · Neurology · doi:10.1212/01.wnl.0000073624.13436.32 · Cited by 103
JOKIC, R., KLIMASZEWSKI, A., MINK, J., & FITZPATRICK, M. F. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.5.9708070 · Cited by 85 · cited 1×
“compounds with surface tension lowering effects ( 36 ).”
BackgroundHARTVIG, P., Wiklund, L., & Lindström, B. (1986) · Acta Anaesthesiologica Scandinavica · doi:10.1111/j.1399-6576.1986.tb02392.x · Cited by 80 · cited 1×
“The target plasma concentration was 3 ng/ml based on a previous study by Hartvig and coworkers ( 16 ), who reported a total plasma clearance of 40 ml/minute kg after intravenous administration in patients who underwent 1250 AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE VOL 168 2003”
MethodKass, J. E., Akers, S. M., Bartter, T. C., & Pratter, M. R. (1996) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.154.1.8680674 · Cited by 72
Hallak, M. E., & Giacobini, E. (1986) · Neurochemical Research · doi:10.1007/bf00965592 · Cited by 62 · cited 1×
“Inhibition of AChE by PHYS has been shown to elevate brain (23, 24 ) and peripheral acetylcholine content in several animal species as well as in humans in a study of brain slices from patients with Alzheimer’s disease (25).”
BackgroundContribution of cholinergic systems to state-dependent modulation of respiratory control
Bellingham, M. C., & Ireland, M. F. (2002) · Respiratory Physiology & Neurobiology · doi:10.1016/s1569-9048(02)00043-5 · Cited by 58 · cited 1×
“medulla oblongata ( 31 , 32) as well in chemosensory signaling in the carotid body (33).”
BackgroundPhysostigmine alters onset but not duration of REM sleep in man
Gillin, J. C., Sitaram, N., Mendelson, W. B., & Wyatt, R. J. (1978) · Psychopharmacology · doi:10.1007/bf00426799 · Cited by 57 · cited 2×
“of REM sleep latency in man ( 11 ) we found that the proportion of REM sleep was”
BackgroundBaghdoyan, H. A. (1997) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1997.273.3.r896 · Cited by 55
Impact of brainstem sleep mechanisms on pharyngeal motor control
Horner, R. L. (2000) · Respiration Physiology · doi:10.1016/s0034-5687(99)00106-1 · Cited by 52 · cited 1×
“the respiratory control system have been proposed (1, 2 ). Thus, reduced upper airway”
BackgroundSafety and Efficacy of Oral Physostigmine in the Treatment of Alzheimer Disease
Sano, M., Bell, K. L., Harder, K., Stricks, L., Stern, Y., & Mayeux, R. P. (1993) · Clinical Neuropharmacology · doi:10.1097/00002826-199302000-00007 · Cited by 48 · cited 1×
“agent in geriatric memory dysfunction and Alzheimer’s disease ( 18 , 19).”
BackgroundInfluence of the Cholinergic Agonist RS 86 on normal sleep: Sex and age effects
Riemann, D. W., Joy, D., Höchli, D., Lauer, C. J., Zulley, J., & Berger, T. (1988) · Psychiatry Research · doi:10.1016/0165-1781(88)90056-x · Cited by 48 · cited 1×
“proportionally small effects on total sleep time in animals and man ( 29 ) but the general”
BackgroundEffects of physostigmine on brain acetylcholine content and release
Bartolini, A., Bartolini, R., & Domino, E. F. (1973) · Neuropharmacology · doi:10.1016/0028-3908(73)90127-5 · Cited by 44 · cited 1×
“Inhibition of AChE by PHYS has been shown to elevate brain ( 23 , 24) and peripheral acetylcholine content in several animal species as well as in humans in a study of brain slices from patients with Alzheimer’s disease (25).”
BackgroundGIACOBINI, E., Somani, S., McIlhany, M., Downen, M., & Hallak, M. (1987) · Neuropharmacology · doi:10.1016/0028-3908(87)90059-1 · Cited by 34 · cited 1×
“elimination half-life, 21.7 minutes ( 22 ), the current study used intravenous administration”
MethodInfluentialO'Donnell, C. P., Schwartz, A. R., & Smith, P. L. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.162.5.ed11-00b · Cited by 33
Pharmacokinetics and pharmacodynamics of physostigmine in the rat after oral administration
Somani, S. M. (1989) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.2510100208 · Cited by 21 · cited 1×
“PHYS include rapid and complete absorption from the gastrointestinal tract, fairly extensive hepatic clearance, moderate binding to plasma proteins, widespread distribution including the central nervous system, and almost complete metabolic elimination (20, 21 ).”
BackgroundAlternatives in the treatment of memory loss in patients with Alzheimer's disease.
Volger, B. W. (1991) · PubMed · Cited by 20
Hedner, E., Birkhed, D., Hedner, J. A., Ekström, J., & Helander, H. F. (2001) · European Journal Of Oral Sciences · doi:10.1034/j.1600-0722.2001.00129.x · Cited by 18 · cited 1×
“includes salivary secretion in that follows PHYS administration ( 35 ).”
BackgroundSelf-citationAcetylcholine is Released from in vitro Cat Carotid Bodies During Hypoxic Stimulation
F, R. S., S, M., & W, H. Y. (2002) · Advances in experimental medicine and biology · doi:10.1007/0-306-46825-5_47 · Cited by 17
Liquid chromatographic analysis of physostigmine salicylate and its degradation products
Rubnov, S., Levy, D., & Schneider, H. (1999) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/s0731-7085(98)00099-5 · Cited by 16 · cited 1×
“concentration of PHYS using a previously described HPLC technique ( 17 ).”
MethodPhysiological pharmacokinetic and pharmacodynamic model of physostigmine in the rat.
Somani, S. M., Gupta, S. K., Khalique, A., & Unni, L. K. (1991) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)07203-4 · Cited by 14
Nonvagal Modulation of Hypoglossal Neural Activity
Haxhiu, M. A., Cherniack, N. S., Mitra, J., van Lunteren, E., & Strohl, K. (2009) · Respiration · doi:10.1159/000196029 · Cited by 13 · cited 1×
“PHYS administered locally to anesthetized, vagotomized, and artificially ventilated cats resulted in a phase shifting of the hypoglossal-to-phrenic nerve temporal firing properties ( 34 ), and it remains possible that alterations in these mechanisms may have accounted for the differences between lean and more obese su…”
BackgroundHerpes simplex virus antigens in sera of patients with Behcet's disease
Hamza, M., & Slim, A. F. (1991) · Clinical Rheumatology · doi:10.1007/bf02206674 · Cited by 6
Research works printed but not linked: 37
- 1997, Sleep, 654
- 2000, Respir Physiol, 113
- 2000, Am J Respir Crit Care Med, 740
- 1992, Am Rev Respir Dis, 1246
- 1998, Am J Respir Crit Care Med, 586
- 1978, J Appl Physiol, 931
- 1989, Curr Pulmonol, 265
- 2000, Respir Physiol, 167
- 1998, CNS Drug Rev, 87
- 1996, Pharmacol Rev, 179
- 1978, Psychopharmacology (Berl), 111
- 2003, Neurology, 35
- 2002, Am J Respir Crit Care Med, A725
- 1992, Sleep, 174
- 1986, Acta Anaesthesiol Scand, 177
- 1999, J Pharm Biomed Anal, 939
- 1993, Clin Neuropharmacol, 61
- 1991, Clin Pharm, 447
- 1985, Pharmacologist, 396
- 1989, Biopharm Drug Dispos, 187
- 1987, Neuropharmacology, 831
- 1973, Neuropharmacology, 15
- 1986, Neurochem Res, 1037
- 1986, J Neural Transm, 275
- 1991, Drug Metab Dispos, 655
- 1997, Am J Physiol, R896
- 2002, Sleep, 307
- 1988, Psychiatry Res, 137
- 2000, Am J Respir Crit Care Med, 1606
- 2002, Respir Physiol Neurobiol, 135
- 2000, Respir Physiol, 111
- 2000, Adv Exp Med Biol, 485
- 1992, Respiration (Herrlisheim), 65
- 2001, Eur J Oral Sci, 371
- 1998, Am J Respir Crit Care Med, 1522
- 2002, N Engl J Med, 404
- 1996, Am J Respir Crit Care Med, 167
Cited by
Pathophysiology of Sleep Apnea
Dempsey, J. A., Veasey, S. C., Morgan, B. J., & O'Donnell, C. P. (2010) · Physiological Reviews · doi:10.1152/physrev.00043.2008 · Cited by 2,243
Obstructive sleep apnoea syndrome
Lévy, P., Kohler, M., McNicholas, W. T., Barbé, F., McEvoy, R. D., Somers, V. K., Lavie, L., & Pépin, J.-L. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.15 · Cited by 1,235
Non-CPAP therapies in obstructive sleep apnoea
Randerath, W. J., Verbraecken, J., Andreas, S., Bettega, G., Boudewyns, A., Hamans, E., Jalbert, F., Paoli, J. R., Sanner, B., Smith, I., et al. (2011) · European Respiratory Journal · doi:10.1183/09031936.00099710 · Cited by 388
Sleep, Anesthesiology, and the Neurobiology of Arousal State Control
Lydic, R., & Baghdoyan, H. A. (2005) · Anesthesiology · doi:10.1097/00000542-200512000-00024 · Cited by 251
Marshall, N. S., Yee, B. J., Desai, A. V., Buchanan, P. R., Wong, K. K., Crompton, R., Melehan, K. L., Zack, N., Rao, S. G., Gendreau, R. M., et al. (2008) · Sleep · doi:10.1093/sleep/31.6.824 · Cited by 224
Metadata
- Authors
- Hedner, J., Kraiczi, H., Peker, Y., & Murphy, P.
- Affiliations
- Sahlgrenska University Hospital (SE)
- Sleep Laboratory, Departments of Pulmonary Medicine and Clinical Pharmacology; and Sahlgrenska University Hospital, Göteborg, Sweden
- ORCID
- Hedner, Jan
- Venue
- American Journal of Respiratory and Critical Care Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 2003-11
- Volume
- 168
- Issue
- 10
- Pages
- 1246-1251
- ISSN
- 1073-449X (ISSN-L)
- 1535-4970
- OpenAlex
- W2149626929
- Cited by
- 81
- References
- 37
- Citations by year
- 2026: 2 · 2025: 1 · 2024: 3 · 2023: 2 · 2022: 4 · 2021: 2 · 2020: 2 · 2019: 3 · 2018: 1 · 2017: 2 · 2016: 4 · 2015: 5 · 2013: 5 · 2012: 6
- FWCI
- 3.56
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- American Journal of Respiratory and Critical Care Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Obstructive Sleep Apnea Research
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Neuroscience of respiration and sleep
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Sleep and related disorders
- Keywords
- physostigmine, obstructive sleep apnea, cholinesterase inhibitors, REM sleep apnea, apnea-hypopnea index, nocturnal oxygen saturation, heart rate variability, sleep duration, body mass index, sleep-disordered breathing
- MeSH terms
- Adult, Cholinesterase Inhibitors, Double-Blind Method, Humans, Male, Middle Aged, Physostigmine, Severity of Illness Index, Sleep, REM, Time Factors, Body Mass Index, Polysomnography, Cross-Over Studies, Sleep Apnea, Obstructive
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.